In this online CME self-learning program:
Alcohol use disorder (AUD), referred to colloquially as alcoholism, is an integration of past terms that have include in past as alcohol dependence or abuse, and may be marked by any one of a number of different symptoms or behaviors that include physical cravings, compulsion, guilt, and frequent consumption over an extended period of time. A quarter of adults report at least one day of heavy drinking over the past year. Alcohol accounts for over 687,000 emergency department visits in the U.S. by people under age 20 per year; worldwide, 76.3 million people are estimated to have AUDs, and they account for an annual mortality rate of 1.8 million. AUD is largely under-recognized and undertreated, constituting one gap in care and justifying continuing HCP education. HCPs are considered well-positioned to be able to recognize AUD, and one of the first missed opportunities to do so is failing to employ a validated screening tool, which might identify a condition well before it reaches the full scale of its adverse psychosocial potential.
HCPs who are: psychiatrists, primary care physicians, emergency medicine physicians, physician assistants, nurse practitioners, pharmacists, and those who otherwise commonly treat patients suffering from or have a clinical interest in AUD.
This program is supported by an educational grant from Alkermes.
Learners may participate in this activity free of charge.
Release Date: September 25, 2020 -- Expiration Date: September 25, 2022
Faculty: John Tsuang, MD
Faculty introduction, disclosures
Primer on AUD’s epidemiology, what is known in the neuropathophysiology, screening strategies, and psychosocial impact
Treatment of AUD
Summary, conclusions, and best practice recap
By the end of the session the participant will be able to:
ACCME Activity #201861270ACCREDITATION FOR THIS COURSE HAS EXPIRED. YOU MAY VIEW THE PROGRAM, BUT CME / CE IS NO LONGER AVAILABLE AND NO CERTIFICATE WILL BE ISSUED.
As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review ScientiaCME.
Faculty Disclosure: John W. Tsuang, MD, Clinical Professor, Department of Psychiatry, University of California Los Angeles, has no relevant conflicts of interest to disclose.
Disclosures of Educational Planners: Charles Turck, PharmD, BCPS, BCCCP, has no relevant conflicts of interest to disclose.
Disclosures of Peer Reviewers:
Steven L. Schandler, PhD, has no relevant conflicts of interest to disclose.
Elizabeth Lorde-Rollins, MD, MSc, has no relevant conflicts of interest to disclose.
Commercial Support Disclosure: This program is supported by an educational grant from Alkermes.
*Required to view Printable PDF Version
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.